The results showed that the methylation levels of FAM83E (Fig. 11), CD79A (Fig. 12), and SPINK7 (Fig. 13) were reduced in tumor tissues with poor clinical staging, while DKK1 was elevated in tumor tissues (Fig. 14). Here, CD79A is linked to neoplasm.